Chunghwa Chemical Synthesis & Biotech Co., Ltd. (TPE:1762)

TPE:1762 Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	275.13	222.28	269.57	300.61	195.25	148.63
Cash & Short-Term Investments	275.13	222.28	269.57	300.61	195.25	148.63
Cash Growth	122.85%	-17.54%	-10.33%	53.96%	31.37%	46.83%
Accounts Receivable	121.64	194.67	248.37	301.49	379.88	357.93
Other Receivables	10.75	13	9	10.86	16.13	9.67
Receivables	132.38	207.67	257.37	312.34	396.01	367.6
Inventory	975.48	969	1,211	819.95	753.85	481.24
Prepaid Expenses	35.12	42.28	49.82	16.08	11.97	4.13
Total Current Assets	1,418	1,441	1,788	1,449	1,357	1,002
Property, Plant & Equipment	2,163	2,199	2,292	1,964	1,868	1,542
Long-Term Investments	1,031	1,002	994.48	998.25	1,060	543.89
Other Intangible Assets	2.99	3.77	5.56	7.53	1.8	1.29
Long-Term Deferred Tax Assets	46.14	35.55	20.44	20.14	24.48	16.76
Other Long-Term Assets	83.79	80.91	71.27	125.42	69.35	41.24
Total Assets	4,745	4,763	5,172	4,564	4,381	3,147
Accounts Payable	32.17	41.44	104.36	144.33	78.77	97.71
Accrued Expenses	40.57	57.75	122.22	193.56	143.72	140.91
Short-Term Debt	249.88	150	500	100	150	-
Current Portion of Leases	3.37	2.91	3.36	2.54	1.32	2.25
Current Income Taxes Payable	6.9	1.82	10.59	49.98	31.05	106.54
Current Unearned Revenue	124.36	124.31	15.91	53.95	73.99	3.66
Other Current Liabilities	35.35	47.06	74.97	69.83	156.34	49.09
Total Current Liabilities	492.6	425.29	831.41	614.18	635.17	400.16
Long-Term Debt	600	700	700	500	600	-
Long-Term Leases	2.73	3.98	4.47	0.72	1.02	0.82
Long-Term Unearned Revenue	9.66	12.74	27	-	-	-
Long-Term Deferred Tax Liabilities	264.49	263.79	258.54	256.22	250.3	247.5
Total Liabilities	1,369	1,406	1,821	1,371	1,486	648.48
Common Stock	775.6	775.6	775.6	775.6	775.6	775.6
Additional Paid-In Capital	334.53	334.53	334.53	334.32	334.32	334.32
Retained Earnings	2,319	2,312	2,296	2,129	1,744	1,385
Comprehensive Income & Other	-53.78	-65.17	-55.48	-46.05	39.76	3.72
Total Common Equity	3,376	3,357	3,350	3,193	2,894	2,498
Minority Interest	-	-	-	0.19	0.19	0.26
Shareholders' Equity	3,376	3,357	3,350	3,193	2,894	2,499
Total Liabilities & Equity	4,745	4,763	5,172	4,564	4,381	3,147
Total Debt	855.98	856.89	1,208	603.26	752.34	3.07
Net Cash (Debt)	-580.85	-634.61	-938.26	-302.65	-557.09	145.55
Net Cash Per Share	-11.43	-11.27	-12.01	-3.86	-7.11	1.86
Filing Date Shares Outstanding	77.56	77.56	77.56	77.56	77.56	77.56
Total Common Shares Outstanding	77.56	77.56	77.56	77.56	77.56	77.56
Working Capital	925.51	1,016	956.37	834.81	721.91	601.44
Book Value Per Share	43.52	43.28	43.20	41.17	37.31	32.21
Tangible Book Value	3,373	3,353	3,345	3,185	2,892	2,497
Tangible Book Value Per Share	43.48	43.23	43.12	41.07	37.29	32.20
Land	1,092	1,092	1,092	741.4	741.4	741.4
Buildings	949.3	948.27	936.09	900.62	826.11	674.26
Machinery	2,490	2,456	2,389	2,296	2,032	1,761
Construction In Progress	35.18	59.46	48.39	27.85	126.44	112.29

Updated Mar 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.